Respiratory and Systemic Effects of LASSBio596 Plus Surfactant in Experimental Acute Respiratory Distress Syndrome

Background/Aims: Exogenous surfactant has been proposed as adjunctive therapy for acute respiratory distress syndrome (ARDS), but it is inactivated by different factors present in the alveolar space. We hypothesized that co-administration of LASSBio596, a molecule with significant anti-inflammatory...

Full description

Bibliographic Details
Main Authors: Johnatas Dutra Silva, Gisele Pena de Oliveira, Cynthia dos Santos Samary, Carla Cristina Araujo, Gisele de Araujo Padilha, Fernando Costa e Silva Filho, Rosilane Taveira da Silva, Marcelo Einicker-Lamas, Marcelo Marcos Morales, Vera Luiza Capelozzi, Vanessa Martins da Silva, Lídia Moreira Lima, Eliezer Jesus Barreiro, Bruno Lourenço Diaz, Paolo Pelosi, Pedro Leme Silva, Cristiane Souza Nascimento Baez Garcia, Patricia Rieken Macedo Rocco
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2016-02-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:http://www.karger.com/Article/FullText/443037